Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status

Benzer Materyaller

• Colorimetric In Situ Hybridization Identifies MYC Gene Signal Clusters Correlating With Increased Copy Number, mRNA, and Protein in Diffuse Large B-cell Lymphoma
  Yazar:: Valentino, Carlo, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
  Yazar:: Iqbal, Javeed, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
  Yazar:: Johnson, Nathalie A., ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• BCL2 Antibodies Targeted At Different Epitopes Detect Varying Levels of Protein Expression and Correlate with Frequent Gene Amplification in Diffuse Large B Cell Lymphoma
  Yazar:: Kendrick, Samantha L., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression
  Yazar:: Rimsza, Lisa M., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)